echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Fudge: the United States will promote three phase clinical trials of three new crown candidate vaccines

    Fudge: the United States will promote three phase clinical trials of three new crown candidate vaccines

    • Last Update: 2020-06-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    Xinhua news agency, Washington, June 10 (reporter Tan Jingjing) Anthony fudge, director of the National Institute of allergy and infectious diseases and an important member of the White House coronavirus response team, said Thursday that the U.Sgovernment will fund three phase clinical trials of three candidate vaccines for new coronavirus< br / > fudge said in an interview with the US media that the three phase clinical trials of the mrna-1273 vaccine developed by Modena in the US will be the first in July; the three phase clinical trials of the vaccine jointly developed by Astra jerichon in the UK and Oxford University will be started in August; and the three phase clinical trials of the new crown vaccine of Johnson & Johnson in the US will be started in September< br / > fudge said that the clinical trial plan of the vaccine was in line with his previous schedule, and the large-scale application of the new crown vaccine would wait until the end of this year or the beginning of next year< br / > according to CNN, each of the three clinical trials will be conducted in more than 50 locations, most of which are in the United States, and 30000 people will participate in these trials< br / > Robert Scully, director of the Department of infectious diseases at the University of California, San Diego, said in an interview with Xinhua news agency that it is relatively easy for the candidate vaccine to enter the first phase of clinical trials and it needs to meet the conditions such as enabling the immune system to recognize virusesAfter evaluating the safety of the candidate vaccine and its induced immune response in the first and second phase clinical trials, the vaccine with significant effect will enter the large-scale third phase clinical trialsPhase III clinical trials need a larger sample size, mainly to evaluate the effectiveness of vaccines in reducing infection rate< br / > in the middle of May, President trump of the United States announced a key research plan called "operation qusu" to accelerate the research on new crown vaccines, drugs, testing and other aspects, and said that he expected to develop new crown vaccines by the end of this year.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.